ConvaTec: ConvaTec posts strong results on broad-based chronic care growth
ConvaTec shares were rising on Wednesday morning after it reported a strong set of financial results for 2024, with revenue rising 6.9% to $2.29bn, supported by broad-based growth across its chronic care categories.
Read full article »
ConvaTec is an England based medical device company that develops and commercializes critical care and infusion devices for the treatment of chronic conditions.
Read more